Serenity Bioworks is developing an immune-compatible gene therapy platform. Their first product will be a re-dosable gene therapy for MEN-1.
Now accepting early applications for the next 2021 batch!
Copyright All Rights Reserved © 2021 SOSV LLC – IndieBio™ is a trademark of SOSV. All other trademarks are of their respective owners.
Start typing and press Enter to search